Skip to main content
AAPA 2025 Annual Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Invitation Only
Invitation Only
Ticketed - Complimentary
Ticketed - Complimentary
Ticketed - Additional Fee Required
Ticketed - Additional Fee Required
Capturing for On Demand
Capturing for On Demand
Pharmacology
Pharmacology
National Health Priorities
National Health Priorities
Potential State Requirement
Potential State Requirement
Project Innovation
Project Innovation
PA Administrative Competencies
PA Administrative Competencies

DERM-Dermatology

RHEU-Rhematology

Satellite Symposium: Raising the Bar on Obesity Management in Psoriasis and Psoriatic Arthritis: A Collaborative Learning Experience for Dermatology and Rheumatology Healthcare Professionals

Sunday, May 18, 2025
5:45 PM – 7:30 PM  
Location: Colorado Convention Center, Mile High Ballroom 4

This activity is approved for 1.50 AAPA Category 1 CME credits.

Please click here to register to for this session to attend in person or virtually.

Psoriasis (PsO), psoriatic arthritis (PsA), and obesity are distinct conditions that are interrelated in prevalence and share complex immunopathogenic mechanisms. Evidence indicates that overlap in these conditions results in a feedback cycle that exacerbates each condition’s effects. Current guidelines and expert consensus recommend an integrated whole-person approach to managing patients with PsO and PsA and comorbid obesity. In this program, expert faculty explore this topic in depth including: (1) understanding the bidirectional relationship between PsO/PsA and obesity, (2) recommended screening and management practices for obesity and related comorbidities, and (3) patient-centered approaches to navigating sensitive conversations while integrating patient goals and preferences into management decisions for patients with PsO/PsA and comorbid obesity.

This activity is supported by an educational grant from Lilly.

This symposium is neither supported, sponsored, nor endorsed by AAPA.

Learning Objectives:

At the conclusion of this session, participants should be able to:
  • Evaluate the evidence for the correlation between PsO, PsA, and obesity, including obesity-associated comorbidities
  • Implement recommended screening and management practices for obesity in patients with PsO and/or PsA
  • Apply expert guidance to have clear, yet compassionate and culturally sensitive conversations with patients around weight and metabolic health
  • Integrate patient goals and preferences into management plans for patients with PsO/PsA and obesity